Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma

Author:

Huang Kaijun1,Zhou Qian2,Wang Rong1,Cheng Donghui1,Ma Yi1

Affiliation:

1. Organ Transplant Center; First Affiliated Hospital of Sun Yat-sen University; Guangzhou China

2. Department of Medical Statistics and Epidemiology; School of Public Health; Sun Yat-sen University; Guangzhou China

Funder

National undergraduate innovation training programs

National Natural Science Foundation of China

Guangdong Natural Science Foundation

Science and Technology Planning Project of Guangdong Province, China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J. Clin. Oncol.,2009

2. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis;Bolondi;Gut,2001

3. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance;Sangiovanni;Gastroenterology,2004

4. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

5. Preliminary assessment of utility of radiofrequency ablation technique in treatment of primary hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis;Witczak-Malinowska;Med. Sci. Monit.,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3